Physician profile
Julia Bratton
NPI 1861079212
$7,736.99
in general payments reported to CMS, 2019-2025
51 companies · $1,929 in 2025
The $1,929 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.43 · 2022: $2,472 · 2023: $1,618 · 2024: $1,639 · 2025: $1,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,136 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,136.12 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $1,382.00 | 2022 | |
| Abbvie INC. | $984.50 | 2022-2025 | |
| Novo Nordisk INC | $587.13 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $476.32 | 2022-2025 | Evenity, Prolia, Repatha |
| Corium, LLC | $449.22 | 2023-2025 | Azstarys |
| Lilly USA, LLC | $426.31 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $350.17 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $336.79 | 2021-2025 | |
| Astellas Pharma US INC | $312.51 | 2023-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $243.23 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $202.96 | 2025 | Auvelity, Symbravo |
| Stryker Corporation | $166.01 | 2024 | Mako |
| Sumitomo Pharma America, INC. | $164.23 | 2023-2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.14 | 2024-2025 | Xifaxan |
| Amarin Pharma, INC. | $157.03 | 2021-2023 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $140.89 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Heartflow, INC. | $90.07 | 2024 | |
| Sanofi-Aventis U.S. LLC | $87.66 | 2022-2025 | |
| Dexcom, INC. | $75.01 | 2024-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $68.67 | 2025 | Korlym |
| Esperion Therapeutics, INC. | $54.63 | 2022-2023 | Nexletol |
| Mayne Pharma Commercial LLC | $53.33 | 2025 | |
| Sunovion Pharmaceuticals INC. | $52.64 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Avvisto Therapeutics, LLC | $49.96 | 2024-2025 | Cycloset |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.38 | 2022 | |
| Exact Sciences Corporation | $44.82 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $39.22 | 2022-2025 | Trintellix |
| Si-Bone, INC. | $37.65 | 2023 | |
| Merck Sharp & Dohme LLC | $37.20 | 2022-2024 | Capvaxive, Gardasil 9, Gardasil |
| Xeris Pharmaceuticals, INC. | $36.10 | 2022-2025 | Keveyis |
| Janssen Pharmaceuticals, INC | $32.95 | 2023-2024 | Spravato |
| Alnylam Pharmaceuticals INC. | $25.44 | 2023 | Oxlumo |
| Scilex Pharmaceuticals INC. | $23.61 | 2022 | |
| Mylan Specialty L.P. | $22.10 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.31 | 2025 | Rexulti |
| Intuity Medical INC | $19.94 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Paratek Pharmaceuticals, INC. | $19.24 | 2025 | Nuzyra |
| Verity Pharmaceuticals INC. | $18.64 | 2024 | Tlando |
| Noven Therapeutics, LLC | $17.88 | 2023 | Secuado |
| Mycovia Pharmaceuticals, INC. | $17.65 | 2022 | |
| Ani Pharmaceuticals, INC. | $16.55 | 2025 | Purified Cortrophin Gel |
| Renalytix Ai, INC. | $15.92 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Genentech USA, INC. | $15.84 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.76 | 2023 | Voquezna |
| Almatica Pharma LLC | $15.64 | 2023 | Loreev Xr |
| Halozyme INC | $15.59 | 2023 | |
| Sanofi Pasteur INC. | $15.08 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.51 | 2025 | Zoryve |
| Antares Pharma, INC. | $13.34 | 2022 | |
| Acerus Pharmaceuticals Corporation | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Bratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.